De-escalation of Neoadjuvant Treatment (Paclitaxel + HP) in Early HER2+ Breast Cancer
Clinical trial NCT07421141 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07421141
- Sponsor
- National Medical Research Radiological Centre of the Ministry of Health of Russia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2025-12-10
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.